Related Experiment Video
Updated: Feb 20, 2026
Identification and Characterization of Protein Glycosylation using Specific Endo- and Exoglycosidases
Published on: December 26, 2011
A Chemoenzymatic Histology Method for O-GlcNAc Detection
Aime Lopez Aguilar1, Xiaomeng Hou1, Liuqing Wen2
1Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Abstract:
Modification of nuclear and cytoplasmic proteins by the addition or removal of O-GlcNAc dynamically impacts multiple biological processes. Here, we present the development of a chemoenzymatic histology method for the detection of O-GlcNAc in tissue specimens. We applied this method to screen murine organs, uncovering specific O-GlcNAc distribution patterns in different tissue structures. We then utilized our histology method for O-GlcNAc detection in human brain specimens from healthy donors and donors with Alzheimer's disease and found higher levels of O-GlcNAc in specimens from healthy donors. We also performed an analysis using a multiple cancer tissue array, uncovering different O-GlcNAc levels between healthy and cancerous tissues, as well as different O-GlcNAc cellular distributions within certain tissue specimens. This chemoenzymatic histology method therefore holds great potential for revealing the biology of O-GlcNAc in physiopathological processes.
Insights
A new chemoenzymatic histology method detects O-GlcNAc protein modification in tissues. This method revealed distinct O-GlcNAc patterns in healthy and diseased human tissues, including Alzheimer's and cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Histology
Background:
- Protein O-GlcNAcylation (O-GlcNAc) is a dynamic post-translational modification regulating numerous cellular processes.
- Understanding O-GlcNAc localization and levels is crucial for deciphering its role in health and disease.
Purpose of the Study:
- To develop and validate a novel chemoenzymatic histology method for detecting O-GlcNAc in tissue specimens.
- To investigate O-GlcNAc distribution patterns in various murine and human tissues.
- To compare O-GlcNAc levels in healthy versus diseased human tissues, including Alzheimer's disease and cancer.
Main Methods:
- Development of a chemoenzymatic histology technique for targeted O-GlcNAc detection.
- Application of the method to screen murine organs for O-GlcNAc distribution.
- Analysis of human brain and cancer tissue arrays using the developed histology method.
Main Results:
- The chemoenzymatic method successfully detected O-GlcNAc in tissue specimens.
- Specific O-GlcNAc distribution patterns were identified in different murine tissue structures.
- Human brain tissues from healthy donors showed higher O-GlcNAc levels compared to Alzheimer's disease specimens.
- Differential O-GlcNAc levels and cellular distributions were observed between healthy and cancerous tissues.
Conclusions:
- The developed chemoenzymatic histology method is effective for visualizing O-GlcNAc in diverse tissue types.
- This method provides valuable insights into O-GlcNAc dysregulation in pathological conditions like Alzheimer's disease and cancer.
- The technique holds significant potential for advancing research into the biological roles of O-GlcNAc in physiology and disease.
